AXSOME THERAPEUTICS, INC. Weighted Average Number of Shares Outstanding, Basic and Diluted
AXSOME THERAPEUTICS, INC. (AXSM) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 38.32 million shares for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-02.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2022-05-02
- AXSOME THERAPEUTICS, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2022-03-31 was 38.32M shares, a 2.39% increase year-over-year.
- AXSOME THERAPEUTICS, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-12-31 was 37.77M shares, a 1.11% increase year-over-year.
- AXSOME THERAPEUTICS, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-09-30 was 37.68M shares, a 0.99% increase year-over-year.
- AXSOME THERAPEUTICS, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-06-30 was 37.60M shares, a 1.33% increase year-over-year.
- AXSOME THERAPEUTICS, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2021 was 37.62M shares, a 1.11% increase from fiscal 2020.
- AXSOME THERAPEUTICS, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2020 was 37.21M shares, a 9.37% increase from fiscal 2019.
- AXSOME THERAPEUTICS, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2019 was 34.02M shares, a 26.55% increase from fiscal 2018.
- AXSOME THERAPEUTICS, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2018 was 26.88M shares, a 18.09% increase from fiscal 2017.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2022-03-31 | 38.32M shares 10-Q · filed 2022-05-02 | 38.04M shares derived: average of 2 quarters · filed 2022-05-02 | 37.92M shares derived: average of 3 quarters · filed 2022-05-02 | 37.84M shares derived: average of 4 quarters · filed 2022-05-02 |
| 2021-12-31 | 37.77M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | 37.72M shares derived: average of 2 quarters · filed 2022-03-01 | 37.68M shares derived: average of 3 quarters · filed 2022-03-01 | 37.62M shares 10-K · filed 2022-03-01 |
| 2021-09-30 | 37.68M shares 10-Q · filed 2021-11-08 | 37.64M shares derived: average of 2 quarters · filed 2021-11-08 | 37.57M shares 10-Q · filed 2021-11-08 | 37.51M shares derived: average of 4 quarters · filed 2022-05-02 |
| 2021-06-30 | 37.60M shares 10-Q · filed 2021-08-09 | 37.51M shares 10-Q · filed 2021-08-09 | 37.46M shares derived: average of 3 quarters · filed 2022-05-02 | 37.42M shares derived: average of 4 quarters · filed 2022-05-02 |
| 2021-03-31 | 37.43M shares 10-Q · filed 2022-05-02 | 37.39M shares derived: average of 2 quarters · filed 2022-05-02 | 37.36M shares derived: average of 3 quarters · filed 2022-05-02 | 37.30M shares derived: average of 4 quarters · filed 2022-05-02 |
| 2020-12-31 | 37.35M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | 37.33M shares derived: average of 2 quarters · filed 2022-03-01 | 37.25M shares derived: average of 3 quarters · filed 2022-03-01 | 37.21M shares 10-K · filed 2022-03-01 |
| 2020-09-30 | 37.31M shares 10-Q · filed 2021-11-08 | 37.21M shares derived: average of 2 quarters · filed 2021-11-08 | 37.16M shares 10-Q · filed 2021-11-08 | 36.56M shares derived: average of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | 37.10M shares 10-Q · filed 2021-08-09 | 37.08M shares 10-Q · filed 2021-08-09 | 36.31M shares derived: average of 3 quarters · filed 2022-03-01 | 35.84M shares derived: average of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | 37.06M shares 10-Q · filed 2021-05-10 | 35.91M shares derived: average of 2 quarters · filed 2022-03-01 | 35.42M shares derived: average of 3 quarters · filed 2022-03-01 | 35.02M shares derived: average of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | 34.77M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | 34.61M shares derived: average of 2 quarters · filed 2022-03-01 | 34.34M shares derived: average of 3 quarters · filed 2022-03-01 | 34.02M shares 10-K · filed 2022-03-01 |
| 2019-09-30 | 34.45M shares 10-Q · filed 2020-11-05 | 34.12M shares derived: average of 2 quarters · filed 2020-11-05 | 33.77M shares 10-Q · filed 2020-11-05 | 32.80M shares derived: average of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | 33.80M shares 10-Q · filed 2020-08-10 | 33.43M shares 10-Q · filed 2020-08-10 | 32.25M shares derived: average of 3 quarters · filed 2021-03-01 | 30.77M shares derived: average of 4 quarters · filed 2021-03-01 |
| 2019-03-31 | 33.05M shares 10-Q · filed 2020-05-11 | 31.48M shares derived: average of 2 quarters · filed 2021-03-01 | 29.76M shares derived: average of 3 quarters · filed 2021-03-01 | 28.77M shares derived: average of 4 quarters · filed 2021-03-01 |
| 2018-12-31 | 29.91M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | 28.12M shares derived: average of 2 quarters · filed 2021-03-01 | 27.34M shares derived: average of 3 quarters · filed 2021-03-01 | 26.88M shares 10-K · filed 2021-03-01 |
| 2018-09-30 | 26.33M shares 10-Q · filed 2019-11-07 | 26.06M shares derived: average of 2 quarters · filed 2019-11-07 | 25.88M shares 10-Q · filed 2019-11-07 | 25.47M shares derived: average of 4 quarters · filed 2020-03-12 |
| 2018-06-30 | 25.79M shares 10-Q · filed 2019-08-08 | 25.65M shares 10-Q · filed 2019-08-08 | 25.18M shares derived: average of 3 quarters · filed 2020-03-12 | 24.79M shares derived: average of 4 quarters · filed 2020-03-12 |
| 2018-03-31 | 25.50M shares 10-Q · filed 2019-05-09 | 24.87M shares derived: average of 2 quarters · filed 2020-03-12 | 24.46M shares derived: average of 3 quarters · filed 2020-03-12 | 24.24M shares derived: average of 4 quarters · filed 2020-03-12 |
| 2017-12-31 | 24.25M shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | 23.94M shares derived: average of 2 quarters · filed 2020-03-12 | 23.83M shares derived: average of 3 quarters · filed 2020-03-12 | 22.76M shares 10-K · filed 2020-03-12 |
| 2017-09-30 | 23.63M shares 10-Q · filed 2018-11-09 | 23.61M shares derived: average of 2 quarters · filed 2018-11-09 | 22.27M shares 10-Q · filed 2018-11-09 | 21.48M shares derived: average of 4 quarters · filed 2019-03-15 |
| 2017-06-30 | 23.60M shares 10-Q · filed 2018-08-08 | 21.58M shares 10-Q · filed 2018-08-08 | 20.76M shares derived: average of 3 quarters · filed 2019-03-15 | 20.36M shares derived: average of 4 quarters · filed 2019-03-15 |
| 2017-03-31 | 19.54M shares 10-Q · filed 2018-05-08 | 19.35M shares derived: average of 2 quarters · filed 2019-03-15 | 19.28M shares derived: average of 3 quarters · filed 2019-03-15 | 19.25M shares derived: average of 4 quarters · filed 2019-03-15 |
| 2016-12-31 | 19.15M shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15 | 19.15M shares derived: average of 2 quarters · filed 2019-03-15 | 19.15M shares derived: average of 3 quarters · filed 2019-03-15 | 19.15M shares 10-K · filed 2019-03-15 |
| 2016-09-30 | 19.15M shares 10-Q · filed 2017-11-08 | 19.15M shares derived: average of 2 quarters · filed 2017-11-08 | 19.15M shares 10-Q · filed 2017-11-08 | 17.98M shares derived: average of 4 quarters · filed 2018-03-07 |
| 2016-06-30 | 19.15M shares 10-Q · filed 2017-08-09 | 19.15M shares 10-Q · filed 2017-08-09 | 17.59M shares derived: average of 3 quarters · filed 2018-03-07 | 15.97M shares derived: average of 4 quarters · filed 2018-03-07 |
| 2016-03-31 | 19.15M shares 10-Q · filed 2017-05-09 | 16.80M shares derived: average of 2 quarters · filed 2018-03-07 | 14.90M shares derived: average of 3 quarters · filed 2018-03-07 | 13.96M shares derived: average of 4 quarters · filed 2018-03-07 |
| 2015-12-31 | 14.46M shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-07 | 12.78M shares derived: average of 2 quarters · filed 2018-03-07 | 12.22M shares derived: average of 3 quarters · filed 2018-03-07 | 11.95M shares 10-K · filed 2018-03-07 |
| 2015-09-30 | 11.11M shares 10-Q · filed 2016-11-14 | 11.11M shares derived: average of 2 quarters · filed 2016-11-14 | 11.11M shares 10-Q · filed 2016-11-14 | |
| 2015-06-30 | 11.11M shares 10-Q · filed 2016-08-09 | 11.11M shares 10-Q · filed 2016-08-09 | ||
| 2015-03-31 | 11.11M shares 10-Q/A · filed 2016-08-09 | |||
| 2014-12-31 | 9.10M shares 10-K · filed 2017-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |